Olmesartan medoxomil treatment potently improves cardiac myosin-induced dilated cardiomyopathy via the modulation of ACE-2 and ANG 1–7 mas receptor
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Olmesartan medoxomil treatment potently improves cardiac myosin-induced dilated cardiomyopathy via the modulation of ACE-2 and ANG 1–7 mas receptor
Authors
Keywords
-
Journal
FREE RADICAL RESEARCH
Volume 46, Issue 7, Pages 850-860
Publisher
Informa UK Limited
Online
2012-04-13
DOI
10.3109/10715762.2012.684878
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Olmesartan, an AT1 Antagonist, Attenuates Oxidative Stress, Endoplasmic Reticulum Stress and Cardiac Inflammatory Mediators in Rats with Heart Failure Induced by Experimental Autoimmune Myocarditis
- (2012) Vijayakumar Sukumaran et al. International Journal of Biological Sciences
- Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47phox NADPH oxidase subunit
- (2011) Sreedhar Bodiga et al. CARDIOVASCULAR RESEARCH
- Beneficial effects of olmesartan, an angiotensin II receptor type 1 antagonist, in rats with dilated cardiomyopathy
- (2011) Vijayakumar Sukumaran et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Telmisartan attenuates oxidative stress and renal fibrosis in streptozotocin induced diabetic mice with the alteration of angiotensin-(1–7)masreceptor expression associated with its PPAR-γ agonist action
- (2011) Arun Prasath Lakshmanan et al. FREE RADICAL RESEARCH
- Telmisartan, a unique ARB, improves left ventricular remodeling of infarcted heart by activating PPAR gamma
- (2011) Yasuhiro Maejima et al. LABORATORY INVESTIGATION
- Olmesartan attenuates the development of heart failure after experimental autoimmune myocarditis in rats through the modulation of ANG 1–7 mas receptor
- (2011) Vijayakumar Sukumaran et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Angiotensin-Converting Enzyme 2 Suppresses Pathological Hypertrophy, Myocardial Fibrosis, and Cardiac Dysfunction
- (2010) JiuChang Zhong et al. CIRCULATION
- Immunohistochemical characterization of infiltrating mononuclea cells in the rat heart with experimental autoimmune giant cell myocarditis
- (2010) M. KODAMA et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- ACE2 Overexpression Ameliorates Left Ventricular Remodeling and Dysfunction in a Rat Model of Myocardial Infarction
- (2010) Yu Xia Zhao et al. HUMAN GENE THERAPY
- Anti-Inflammatory Effects of the Activation of the Angiotensin-(1-7) Receptor, Mas, in Experimental Models of Arthritis
- (2010) K. D. da Silveira et al. JOURNAL OF IMMUNOLOGY
- Telmisartan attenuates aortic hypertrophy in hypertensive rats by the modulation of ACE2 and profilin-1 expression
- (2010) Jiu-Chang Zhong et al. REGULATORY PEPTIDES
- Loss of Angiotensin-Converting Enzyme 2 Accelerates Maladaptive Left Ventricular Remodeling in Response to Myocardial Infarction
- (2009) Zamaneh Kassiri et al. Circulation-Heart Failure
- Angiotensin II Up-Regulates Angiotensin I-Converting Enzyme (ACE), but Down-Regulates ACE2 via the AT1-ERK/p38 MAP Kinase Pathway
- (2008) Vijay Koka et al. AMERICAN JOURNAL OF PATHOLOGY
- Angiotensin(1-7) Blunts Hypertensive Cardiac Remodeling by a Direct Effect on the Heart
- (2008) Chantal Mercure et al. CIRCULATION RESEARCH
- Interplay of angiotensin II and angiotensin(1-7) in the regulation of matrix metalloproteinases of human cardiocytes
- (2008) Chun-Hsu Pan et al. EXPERIMENTAL PHYSIOLOGY
- Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis
- (2008) Robson A. S. Santos et al. EXPERIMENTAL PHYSIOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started